SCIENTURE HOLDINGS, INC. Notes Payable, Current
SCIENTURE HOLDINGS, INC. (SCNX) had Notes Payable, Current of $6.53 million as of 2023-12-31, per its 10-K filed 2024-04-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2024-04-22
- 2023-12-31: Notes Payable, Current $6.53M.
- 2023-09-30: Notes Payable, Current $5.23M.
- 2022-12-31: Notes Payable, Current $166.67K.
- 2021-03-31: Notes Payable, Current $225.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2023-12-31 | $6.53M 10-K · filed 2024-04-22 |
| 2023-09-30 | $5.23M 10-Q · filed 2024-01-16 |
| 2022-12-31 | $166.67K 10-K · filed 2024-04-22 |
| 2021-03-31 | $225.00K 10-Q · filed 2021-04-26 |
| 2020-12-31 | $225.00K 10-Q · filed 2021-04-26 |
| 2017-12-31 | $10.59K 10-K · filed 2019-03-22 |
| 2017-03-31 | $377.57K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $392.38K 10-Q · filed 2017-05-15 |
| 2016-09-30 | $332.10K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $212.50K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $246.25K 10-Q · filed 2016-04-20 |
| 2015-12-31 | $235.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | $223.75K 10-Q · filed 2015-11-02 |
| 2015-06-30 | $212.50K 10-Q · filed 2015-07-30 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |